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Open access under CC BY-NC-ND license.Abstract Phytochemical investigation of the aerial parts of Evolvulus alsinoides Linn. (Convolvu-
lacae) resulted in the isolation of a new chromone characterized as 6-hydroxy-5-nonadecanoxych-
roman-2-one (alsinoideschromone) along with hexatriacontane, octyl octadec-9-enoate, nonyl
octadec-9-enoate, dodecanyl-octadec-9,12-dienoate, tetracosanyl hexadec-9-enoate, heptacosan-
14-b-ol, stigmast-5, 22-dien-3b-ol and stigmata-5-en-3b-ol. The structure of all these phytoconstit-
uents have been established on the basis of spectral data analysis and chemical reactions.
ª 2009 King Saud University. Open access under CC BY-NC-ND license.1. Introduction
Evolvulus alsinoides Linn. (Convolvulacae), commonly known
as Shankhpushpi or Shankhavali, is distributed throughout the
tropical and sub-tropical countries of the world (Anonymous,
2003). It is well known for its therapeutic effect on brain disor-
ders in Ayurvedic system of medicine (Chatterjee, 1990). The
plant is used as a vermifuge and, with oil, for promoting
growth of hair (Kirtikar and Basu, 1999). The plant possesses
antiulcer (Asolkar et al., 1992; Purohit et al., 1996), immuno-modulatory (Lilly et al., 2003), adaptogenic (Siripurapu et al.,
2005) and antioxidant properties (Mukherjee et al., 2003). Phy-
tochemically the plant has been reported to contain aliphatic
hydrocarbons (Mehta and Shah, 1958), sterols (Mehta and
Shah, 1958; Varadan et al., 1958), fatty acids (Varadan
et al., 1958) and alkaloids (Baveja and Singla, 1969; Prajapati
et al., 2003). In the view of very few reports regarding its phy-
tochemistry, we undertook the phytochemical screening of the
aerial parts of E. alsinoides.2. Experimental
2.1. General
Melting points were determined on Perﬁt melting point
apparatus and are uncorrected; IR: Bio-Rad FT-IR
Spectrophotometer in KBr; UV: Lambda Bio-20 Spectropho-
tometer in MeOH; 1H NMR and 13C NMR (300 MHz):
DPX 300, Bruker Spectrospin in CDCl3 and DMSO-d6 with
TMS as an internal standard; mass spectra were scanned by
192 Md. Sohail Akhtar et al.effecting FAB ionization at 70 eV on a JEOL-JMS-DX 303
instrument equipped with direct inlet probe system. The m/z
values of the more intense peaks were mentioned and the ﬁg-
ures in brackets attached to each m/z value indicate relative
intensities with respect to base peak: silica gel (Qualigens),
60–120 mesh; TLC: silica gel G (Qualigens). Spots were visual-
ized by exposure to iodine vapours, UV radiation and by
spraying with ceric ammonium sulphate and perchloric acid.
2.2. Plant material
The aerial parts of E. alsinoides were procured from the Khari
Baoli market of Delhi and were identiﬁed by Dr. M.P. Sharma,
Taxonomist and Reader, Department of Botany, Jamia Ham-
dard, New Delhi. A voucher specimen no. PRL/JH/05/31 is
deposited in the herbarium of the Phytochemical Research
Laboratory, Faculty of Pharmacy, Jamia Hamdard, New
Delhi, India.
2.3. Extraction and isolation of compounds
The dried drug (2 kg) was coarsely powdered, defatted with
petroleum ether and then exhaustively extracted with ethanol
(95%). The combined extracts were then concentrated on a
steam bath and dried under reduced pressure to get 105 g
(5.5% yield) of dark brown mass. The viscous dark brown
mass was dissolved in little quantity of methanol and adsorbed
on silica gel (60–120 mesh) for the preparation of slurry. It was
dried, packed and chromatographed over silica gel column
packed in petroleum ether. The column was eluted with petro-
leum ether, chloroform and methanol successively in the order
of increasing polarity to isolate following compounds:
2.4. Hexatriacontane 1
Elution of the column with petroleum ether (fraction 1–40)
yielded colourless sticky mass of 1, recrystallised from acetone;
80 mg (0.004% yield); Rf: 0.51 (petroleum ether:CHCl3, 1:1);
IR mmax (KBr): 2920, 2850, 1463, 1378, 1020, 720 cm
1;
1HNMR (DMSO-d6): d 1.51 (4H, m, 2 · CH2), 1.28 (56H,
brs, 28 · CH2), 1.23 (8H, brs, 4 · CH2), 0.84 (6H, brs, Me-1,
Me-36); 13C NMR (DMSO-d6): d 31.61 (CH2), 28.56
(32 · CH2), 22.13 (CH2), 14.16 (Me-1, Me-36); +ve ion FAB
MS m/z (rel. int.): 506 [M]+(C36H74).
2.5. Octyl oleate 2
Elution of the column with petroleum ether:CHCl3 (1:1) (frac-
tion 41–60) gave colourless amorphous powder of 2, recrystal-
lised from acetone; 125 mg (0.006% yield); Rf: 0.75
(CHCl3:petroleum ether, 1:1); m.p.: 60–62 C; IR mmax (KBr):
2912, 2850, 1725, 1640, 1329, 1115, 781, 747, 703 cm1; 1H
NMR (DMSO-d6): d 5.34 (1H, m, H-9), 5.11 (1H, m, H-10),
3.65 (2H, brs, H2-1
0), 2.33 (2H, brs, H2-2), 1.63 (4H, brs, H2-
8, H2-11), 1.26 (34H, brs, (17 · CH2), 0.87 (6H, brs, Me-18,
Me-80); 13C NMR (DMSO-d6): d 174.02 (C-1), 129.14 (C-9),
115.40 (C-10), 63.28 (C-10), 36.71 (CH2), 34.89 (CH2), 33.41
(CH2), 30.93 (CH2), 28.65 (CH2), 25.11 (CH2), 24.16 (CH2),
23.47 (CH2), 21.66 (CH2), 20.30 (CH2), 19.07 (CH2), 13.24
(Me-18), 11.35 (Me-8); +ve ion FABMS m/z (rel. int.): 394
[M]+(C26H50O2) (23.1). Hydrolysis of 2 (20 mg) with 1 NKOH solution after usual procedure yielded oleic acid (co-
TLC comparable).2.6. Nonyl oleate 3
Further elution of the column with petroleum ether:CHCl3
(1:1) (fraction 61–80) produced colourless amorphous powder
of 3, recrystallised from acetone; 145 mg (0.007% yield); Rf:
0.73 (CHCl3:petroleum ether, 1:1); m.p.: 70–72 C; IR mmax
(KBr): 2919, 2850, 1736, 1638, 1463, 1377, 1260, 1080, 970,
804, 720 cm1; 1H NMR (CDCl3): d 5.35 (1H, m, H-9), 5.11
(1H, brs, H-10), 4.05 (2H, brs, H2-1
0), 2.04 (2H, brs, H2-2),
1.68 (2H, brs, H2-8), 1.59 (2H, brs, H2-11), 1.25 (30H, brs,
15 · CH2), 1.02 (6H, brs, 3 · CH2), 0.87 (3H, t, J= 6.2 Hz,
Me-18), 0.85 (3H, t, J= 6.2 Hz, Me-90); 13C NMR (CDCl3):
dc 173.11 (C-1), 123.62 (C-9), 121.28 (C-10), 63.17 (C-10),
30.81 (CH2), 28.57 (20 · CH2), 13.37 (Me-18, Me-90); +ve
ion FABMS m/z (rel. int.): 408 [M]+(C27H52O2) (18.6), 265
(39.3), 143 (43.8). Hydrolysis of 3 (25 mg) with 1 N KOH solu-
tion after usual procedure yielded oleic acid (co-TLC
comparable).2.7. Dodecanyl linoleate 4
Elution of the column with petroleum ether:CHCl3 (1:3) (frac-
tion 81–110) afforded colourless amorphous powder of 4,
recrystallised from acetone; 180 mg (0.009% yield). Rf: 0.73
(CHCl3:petroleum ether, 3:1); m.p.: 76–78 C; UV kmax
(MeOH): 242 nm (log e 4.9); IR mmax (KBr): 2918, 2849,
1735, 1638, 1463, 1378, 719 cm1; 1H NMR (CDCl3): d 5.34
(2H, m, H-10, H-12), 5.11 (2H, m, H-9, H-13), 3.63 (2H, m,
H2-1
0), 2.28 (2H, m, H2-11), 2.04 (2H, brs, H2-2), 1.68 (2H,
brs, H2-8), 1.59 (2H, brs, H2-14), 1.25 (30H, brs, 15 · CH2),
1.00 (4H, m, 3 · CH2), 0.87 (3H, t, J= 6.3 Hz, Me-18), 0.85
(3H, t, J= 6 Hz, Me-120); 13C NMR (CDCl3): dc 177.11 (C-
1), 130.88 (C-12), 128.81 (C-13), 124.43 (C-9), 119.08 (C-10),
63.08 (C-10), 39.7 (C-11), 37.29 (C-8), 32.79 (C-14), 31.91
(CH2), 31.42 (CH2), 29.69 (12 · CH2), 26.39 (CH2), 25.72
(CH2), 24.81 (CH2), 24.45 (CH2), 22.68 (CH2), 21.07 (CH2),
19.72 (Me-18), 14.11 (Me-120); +ve ion FABMS m/z (rel.
int.): 448 [M]+(C30H56O2) (9.6), 279 (38.2), 263 (6.1). Hydroly-
sis of 4 (20 mg) with 1 N KOH solution (5 ml) for 30 min on a
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New chromone derivative from Evolvulus alsinoides 1932.8. Tetracosanyl palmoleate 5Further elution of the column with petroleum ether:CHCl3
(1:3) (fraction 111–130) furnished colourless amorphous pow-
der of 5, recrystallised from acetone; 135 mg (0.006% yield);
Rf: 0.62 (CHCl3:petroleum ether, 3:1); m.p.: 85–87 C; UV
kmax (MeOH): 241 nm (log e 2.9); IR mmax (KBr): 2919, 2049,
1728, 1636, 1465, 1282, 1166, 723 cm1; 1H NMR (CDCl3):
d 5.35 (1H, m, H-9), 5.11 (1H, m, H-10), 3.66 (2H, brs, H2-
10), 2.41 (1H, d, J= 7.2 Hz, H2-2a), 2.13 (1H, d, J= 7.2 Hz,
H2-2b), 1.68 (2H, brs, H2-8), 1.60 (2H, brs, H2-11), 1.41 (2H,
m, CH2), 1.37 (2H, brs, CH2), 1.33 (2H, brs, CH2), 1.25
(56H, brs, 28 · CH2), 0.87 (3H, t, J= 6.9 Hz, Me-16), 0.085
(3H, t, J= 6.9 Hz, Me-240); 13C NMR (CDCl3): dc 173.15
(C-1), 124.38 (C-9), 119.08 (C-10), 61.18 (C-10), 39.72 (CH2),
37.37 (CH2), 37.11 (CH2), 36.64 (CH2), 34.39 (CH2), 33.44
(CH2), 30.13 (CH2), 29.70 (18 · CH2), 27.11 (CH2), 26.71
(CH2), 25.02 (CH2), 24.46 (CH2), 22.69 (CH2), 21.03 (Me-
16), 14.11 (Me-240); +ve ion FABMS m/z (rel. int.): 590
[M]+(C40H78O2) (23.8), 253 (9.8), 237(13.6), 111 (37.2), 85
(53.1). Hydrolysis of 2 (25 mg) with 1 N KOH solution
(5 ml) for 30 min on a steam bath and after usual procedure
yielded palmoleic acid (co-TLC comparable).
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Tetracosanyl hexadec-9-enoate (5) 2.9. 14-Heptacosanol 6
Elution of the column with CHCl3 (131–155) yielded a colour-
less amorphous powder of 6 recrystallised from acetone: ethyl
acetate (1:1); 210 mg (0.01% yield); Rf: 0.52 (CHCl3); m.p.:
110–112 C; IR mmax (KBr): 3425, 2935, 2850, 1465, 1380,
1059 cm1; 1H NMR (DMSO-d6): d 4.13 (1H, brs,
w1/2 = 15.6 Hz, H-14a), 2.50 (2H, brs, CH2), 2.19 (2H, brs,
CH2), 1.52 (2H, brs, CH2), 1.27 (42H, brs, 21 · CH2), 0.88
(6H, brs, Me-1, Me-27); 13C NMR (DMSO-d6): d 73.11 (C-
14), 33.32 (CH2), 30.75 (CH2), 28.43 (20 · CH2), 24.06
(CH2), 21.48 (CH2), 13.23 (Me-1, Me-27); +ve ion FABMS
m/z (rel. int.): 396 [M]+(C27H56O) (12.6), 213 (67.3).
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Heptacosan-14-β-ol (6) 2.10. Stigmasterol 7
Elution of the column with CHCl3:MeOH (99:1) (156–185)
yielded colourless amorphous powder of 7 recrystallised from
methanol; 240 mg (0.012% yield); Rf: 0.43 (petroleum
ether:CHCl3:MeOH, 7:1:2); m.p.: 168–170 C; IR mmax (KBr):
3419, 2922, 2852, 1636, 1463, 1378, 1164, 965 cm1; 1H
NMR (DMSO-d6): d 5.16 (1H, brs, H-6), 5.14 (1H, m, H-
22), 5.07 (1H, m, H-23), 1.12 (3H, brs, Me-19), 0.97 (3H, d,
J= 7.8 Hz, Me-21), 0.88 (3H, d, J= 6.5 Hz, Me-26), 0.85
(3H, d, J= 6.3 Hz, Me-27), 0.81 (3H, d, J = 6.0 Hz, Me-
29), 0.68 (3H, brs, Me-18); 13C NMR (DMSO-d6): dc 37.33
(C-1), 31.09 (C-2), 69.74 (C-3), 41.92 (C-4), 141.08 (C-5),
119.83 (C-6), 33.23 (C-7), 34.97 (C-8), 50.18 (C-9), 36.68 (C-
10), 21.09 (C-11), 39.78 (C-12), 41.92 (C-13), 55.98 (C-14),24.34 (C-15), 27.29 (C-16), 55.33 (C-17), 11.48 (C-18), 20.31
(C-19), 35.09 (C-20), 18.65 (C-21), 137.38 (C-22), 128.69 (C-
23), 45.08 (C-24), 28.52 (C-25), 25.73 (C-26), 18.69 (C-27),
23.50 (C-28), 18.71 (C-29); +ve ion FABMS m/z (rel. int.):
412 [M]+(C29H48O) (83.1), 397 (83.6), 394 (62.7), 382 (51.6),




























Stigmast-5, 22-dien-3β-ol (7)2.11. b-Sitosterol 8
Elution of the column with CHCl3:MeOH (24:1) (fraction
186–205) yielded colourless amorphous powder of 8 recrystal-
lised from methanol; 260 mg (0.013% yield); Rf: 0.43 (petro-
leum ether:CHCl3:MeOH::1:4:1); m.p: 137–138 C; IR mmax
(KBr): 3465, 2955, 2845, 1640, 1475, 1365, 1210, 1105 cm1;
1H NMR (CDCl3): d 5.30 (d, J= 5.5 Hz, H-6), 3.51 (1H,
brs, w1/2 = 16.5 Hz, H-3a), 1.01 (3H, brs, Me-19), 0.97 (3
H, d, J= 6.5 Hz, Me-21), 0.86 (3 H, d, J= 6.0 Hz, Me-
29), 0.85 (3 H, d, J= 6.0 Hz, Me-27), 0.82 (3H, t,
J= 6.2 Hz, Me-26), 0.67 (3H, brs, Me-18); 13C NMR
(CDCl3): 37.33 (C-1), 31.63 (C-2), 69.51 (C-3), 41.98 (C-4),
141.17 (C-5), 119.94 (C-6), 31.15 (C-7), 31.81 (C-8), 49.57
(C-9), 36.74 (C-10), 21.66 (C-11), 39.80 (C-12), 41.98 (C-13),
56.04 (C-14), 24.19 (C-15), 28.60 (C-16), 55.41 (C-17), 11.36
(C-18), 19.30 (C-19), 36.74 (C-20), 18.75 (C-21), 33.30 (C-
22), 25.73 (C-23), 45.14 (C-24), 29.15 (C-25), 20.37 (C-26),
19.30 (C-27), 23.56 (C-28), 11.03 (C-29); +ve ion FAB MS
m/z (rel. int.): 414 [M]+(C29H50O) (22.3), 397 (33.1), 395
(35.2), 381 (16.5), 365 (11.3), 339 (12.6), 371 (17.8), 255
(13.2), 239 (9.6), 213 (15.6), 198 (17.9), 159 (39.7), 145




























Stigmata-5-en-3β-ol (8)2.12. Alsinoideschromone 9
Elution of the column with CHCl3:MeOH (93:7) (fraction 206–
220) yielded colourless amorphous powder of 9, recrystal-
lised from methanol; 180 mg (0.009% yield); Rf: 0.45
194 Md. Sohail Akhtar et al.(CHCl3:MeOH; 93:7); m.p.: 120 C; IR mmax (KBr): 3407,
2919, 2850, 1722, 1672, 1604, 1514, 1466, 1207, 1168, 981,
834, 721 cm1; 1H NMR (CDCl3): d 7.44 (1H, d,
J= 7.8 Hz, H-7), 6.86 (1H, d, J= 7.8 Hz, H-8), 4.18 (1H, d,
J= 6.0 Hz, H2-1
0a), 4.11 (1H, d, J= 6.0 Hz, H2-10b), 2.31
(2H, dd, J= 7.5, 5.5 Hz, H2-3), 2.01 (2H, dd, J= 7.5,
5.5 Hz, H2-4), 1.62 (2H, m, H2-2
0), 1.25 (30H, brs,
15 · CH2), 0.87 (3H, t, J = 6.9 Hz, Me-190); 13C NMR
(CDCl3): dc 178.69 (C-2), 162.13 (C-5), 157.68 (C-6), 144.30
(C-8a), 132.31 (C-4a), 129.92 (C-8), 115.84 (C-7), 64.69 (C-1)
33.85 (C-3), 31.92 (C-4), 29.67 (10 · CH2), 29.33 (2 · CH2),
28.78 (CH2), 27.18 (CH2), 25.98 (CH2), 24.77 (CH2), 22.68
(CH2), 14.11 (CH3-19
0); +ve ion FABMS m/z (rel. int.): 446














6-Hydroxy-5-nonadecanoxychroman-2-one (9) 3. Result and discussion
The structures of the known compounds 1–8 were elucidated
as hexatriacontane, octyl octadec-9-enoate, nonyl octadec-9-
enoate, dodecanyl octadec-9,12-dienoate, tetracosanyl hexa-
dec-9-enoate, heptacosan-14-b-ol, stigmast-5, 22-dien-3b-ol
and stigmata-5-en-3b-ol, respectively, on the basis of spectral
data analysis and chemical reactions. All these compounds
have been isolated from E. alsinoides aerial parts for the ﬁrst
time.
Compound 9, designated as alsinoideschromone, was ob-
tained as colourless amorphous powder from chloro-
form:methanol (93:7) eluants. Its IR spectrum displayed
characteristic absorption bands for hydroxyl group
(3407 cm1), carbonyl group (1722 cm1), aromatic moiety
(1604, 1514, 981 cm1) and long aliphatic chain (721 cm1).
The +ve FAB mass spectrum of 9 exhibited a molecular ion
peak at m/z 446 consistent with the molecular formula
C28H46O4. The important ion peaks appearing at m/z 267
[(CH2)18CH3]
+, 179 [M-267]+, 283 [O(CH2)18CH3]
+ and 163
[M-283]+ suggested the presence of C19-aliphatic chain in the
molecule. The 1H NMR spectrum of 9 displayed two down-
ﬁeld doublets, one-proton each, at d 7.44 (J= 7.8 Hz) and
6.86 (J= 7.8 Hz) assigned correspondingly to ortho-coupled
H-7 and H-8 aromatic protons, respectively. Another two
one-proton doublets at d 4.18 and 4.11 with J= 6.0 Hz each,
were attributed to oxygenated nonequivalent methylene pro-
tons H2-1
0a and H2-10b. Two double-doublets at d 2.31 and
2.01 (J= 7.5, 5.5 Hz, each), two-proton each, were ascribed
to methylene protons H2-3 and H2-4, respectively. A two-pro-ton multiplet at d 1.62 was due to H2-20 methylene protons
whereas the remaining methylene protons resonated as a 30-
proton broad signal at d 1.25. A three-proton triplet at d
0.87 (J= 6.9 Hz) was ascribed to terminal primary methyl
Me-190 protons. The 13C NMR spectrum of 9 showed impor-
tant signals for carbonyl carbon at d 178.69 (C-2) and phenolic
carbons C-5 and C-6 at d 162.13 and 157.63. The remaining
aromatic carbons resonated between d 144.30–115.84. The
oxygenated methylene carbon C-10 appeared at d 64.69
whereas the remaining methylene carbons were observed be-
tween d 33.85–22.68. The terminal primary methyl C-190 car-
bon appeared at d 14.11. The 1H–1H COSY spectrum of 9
exhibited correlations of H-7 with H-8; H2-4 with H2-3; and
H2-1
0 with H2-20. The
1H–13C HMBC spectrum of 9 exhibited
interactions of H-6 with C-7 and C-6; H2-1
0 with C-20 and C-6;
and H2-3 with C-2 and C-4. Based on the above spectral data,
the structure of 9 was elucidated as 6-hydroxy-5-nonad-
ecanoxychroman-2-one. This is an unreported chromone
derivative isolated from a natural or synthetic source for the
ﬁrst time.
4. Conclusion
The present work characterized several chemical compounds
from the aerial parts of E. alsinoides. The existing knowledge
regarding its phytoconstituents may be increased by present
investigation and may be quite useful as this drug is highly val-
ued in traditional Indian system of medicine.References
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